Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream

Journal of Dermatological Treatment

Volumn 19, Issue 3, 2008, Pages 156-158

  Ezughah, Francesca I ^a   Affleck, Andrew G ^a,b   Evans, Alan ^a   Ibbotson, Sally H ^a   Fleming, Colin J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Basal cell carcinoma; Histological clearance; Imiquimod

Indexed keywords

IMIQUIMOD; PARAFFIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CHEMOSURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BIOPSY;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 45849122874     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701759603     Document Type: Article

References (7)

1. Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002-7.
2. Vidal D, Matias-Guiu X, Alomar A. Fifty-five basal cell carcinomas treated with topical imiquimod: Outcome at 5-year follow-up. Arch Dermatol. 2007;143:266-8.
3. Schulze HJ, Cribier B, Requena L, Reifenberger L, Ferrandiz C, Garcia Diez A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005;152:939-47.
4. Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Dox TL, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. J Am Acad Dermatol. 2001;44:807-13.
5. Geisse J, Caro I, Lindholm S, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004;50:722-33.
6. Ezughah FI, Dawe RS, Ibbotson SH, Fleming CJ. A randomised parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma. J Dermatolog Treat 2007;3:1-7.
7. Torres A, Niemeyer A, Berkes B, Marra D, Schanbacher C, Gonzalez S, et al. 5% Imiquimod cream and reflectancemode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatol Surg. 2004;30:1462-9.